AdjustedEPS News & Analysis
2 articles
Market Mood
Spectrum Brands (SPB) Q2 Results Exceed Estimates; Price Target Raised
Spectrum Brands Holdings, Inc. (SPB) reported Q2 results with revenue of $708.9M, surpassing the consensus estimate of $677.4M. Adjusted EPS was $1.25, above the expected $1.06, while sales exceeded consensus by approximately 5%. Canaccord raised the price target to $100 from $94, maintaining a Buy rating. The company anticipates adjusted EBITDA growth in the low-to-mid single-digit range for fiscal 2026, with adjusted free cash flow expected to be about 50% of adjusted EBITDA, indicating positive momentum despite challenges in certain segments.
Read More
Haemonetics (HAE) Reports Q4 Revenue of $346 Million, Up 5%
Haemonetics (HAE) announced fiscal Q4 revenue of $346 million, reflecting a 5% increase reported and a 9% rise organically excluding CSL, with adjusted EPS at $1.29. For the full year, revenue reached $1.3 billion, and adjusted EPS stood at $4.96. Key growth drivers included Plasma and Blood Management Technologies, with Plasma revenue at $130 million, up 13% organically. Fiscal 2027 guidance anticipates revenue growth between 4% and 7%, alongside adjusted operating margin expansion of 50 to 100 basis points.
Read More